| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 01/11/2006 | CN1720231A Substituted dihydrophenanthridinesulfonamides |
| 01/11/2006 | CN1720047A PgD2 receptor antagonists for the treatment of inflammatory diseases |
| 01/11/2006 | CN1720043A Non-nucleoside reverse transcriptase inhibitors |
| 01/11/2006 | CN1235898C Cyclohexenondioxothio chromanoyl derivatives |
| 01/10/2006 | US6984737 Di(het)arylaminothiophene derivatives |
| 01/10/2006 | US6984735 Reacting a dihalaromatic compound with sulfoxide |
| 01/10/2006 | US6984660 To treat and/or prevent hypertension, cardiac hypertrophy, cardiac insufficiency, coronary heart diseases such as angina pectoris, and endothelial dysfunction or endothelial damage as a consequence of atherosclerotic processes or diabetes |
| 01/10/2006 | US6984649 Pyridine derivatives |
| 01/10/2006 | US6984648 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 01/10/2006 | US6984647 Antiinflammatory agents; analgesics; antiarthritic agents |
| 01/10/2006 | US6984643 2,5-substituted pyrimidine derivatives-CCR-3 receptor antagonists |
| 01/10/2006 | US6984637 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 01/10/2006 | US6984462 Organic electroluminescent devices using double-spiro organic compounds |
| 01/10/2006 | CA2383332C Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists |
| 01/10/2006 | CA2223918C Pyrrole derivatives and medicinal composition |
| 01/10/2006 | CA2163520C L-2',3'-dideoxy nucleoside analogs as anti-hepatitis b (hbv) and anti-hiv agents |
| 01/05/2006 | WO2006001750A1 Imidazole variants as modulators of gaba receptor for the treatment of gi disorders |
| 01/05/2006 | WO2006000371A2 Pyrimidine derivatives as 11beta-hsd1 inhibitors |
| 01/05/2006 | WO2005085194A3 Indole-2-carboxylic acid hydrazides as glycogen phosphorylase inhibitors |
| 01/05/2006 | WO2004080976A8 Phthalazinone derivatives |
| 01/05/2006 | US20060004075 Substituted aryl amides as IP antagonists |
| 01/05/2006 | US20060004063 Inhibitors of HCV NS5B polymerase |
| 01/05/2006 | US20060004047 Piperidine derivatives as ccr5 inhibitors |
| 01/05/2006 | US20060004041 Compounds for treatment of neurodegenerative diseases |
| 01/05/2006 | US20060004029 Nitrogen-containing aromatic derivatives |
| 01/05/2006 | US20060004013 Cinnamide compound |
| 01/05/2006 | US20060004010 Ccr4 antagonist and medical use thereof |
| 01/05/2006 | US20060004009 Ethylenediamine derivatives |
| 01/05/2006 | US20060004005 Triazines derivatives as cell adhesion inhibitors |
| 01/05/2006 | US20060002853 Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 01/05/2006 | DE102004028973A1 Substituierte Tetrahydro-2H-isochinolin-1-on-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituted tetrahydro-2H-isoquinolin-1-one derivatives, to processes for their preparation and their use as a medicament |
| 01/05/2006 | CA2810655A1 Modulators of atp-binding cassette transporters |
| 01/05/2006 | CA2571949A1 Modulators of atp-binding cassette transporters |
| 01/05/2006 | CA2571258A1 Amido compounds and their use as pharmaceuticals |
| 01/05/2006 | CA2571087A1 Novel piperidine derivates as modulators of chemokine receptor ccr5 |
| 01/05/2006 | CA2570873A1 Pyrimidine urea derivatives as kinase inhibitors |
| 01/05/2006 | CA2570673A1 Compounds and methods for treating dyslipidemia |
| 01/05/2006 | CA2570619A1 Imidazole variants as modulators of gaba receptor for the treatment of gi disorders |
| 01/04/2006 | EP1611127A2 4-substitued quinolein derivatives with antimicrobial activity |
| 01/04/2006 | EP1611122A1 Substituted pyrazole compounds |
| 01/04/2006 | EP1611121A1 Pyridazinone derivatives as cdk2-inhibitors |
| 01/04/2006 | EP1611109A1 Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 01/04/2006 | EP1611107A1 1,3,4-substituted pyrazoles for use as 5-ht receptor antagonists in the treatment of psychoses and neurological disorders |
| 01/04/2006 | EP1611105A1 Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b) |
| 01/04/2006 | EP1611096A2 Benzamide modulators of metabotropic glutamate receptors |
| 01/04/2006 | EP1611088A2 Hydroxamates as therapeutic agents |
| 01/04/2006 | EP1610812A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 01/04/2006 | EP1610780A2 Cyclic protein tyrosine kinase inhibitors |
| 01/04/2006 | EP1610774A2 Tie-2 modulators and methods of use |
| 01/04/2006 | EP1610753A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 01/04/2006 | EP1339677B1 Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis |
| 01/04/2006 | EP1147088B1 6-arylphenanthridines with pde-iv inhibiting activity |
| 01/04/2006 | EP1102755B1 Substituted isoxazole derivatives as estrogen receptor modulators |
| 01/04/2006 | EP0885885B1 Pyridone derivatives and herbicides |
| 01/04/2006 | CN1717406A Method for preparing Oltipraz |
| 01/04/2006 | CN1717400A Tetrahydropyran derivatives |
| 01/04/2006 | CN1717396A Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 01/04/2006 | CN1717250A Anti-cancer and anti-infectious disease compositions and methods for using same |
| 01/04/2006 | CN1717175A Quinolin-, isoquinolin-, and quinazolin-oxyalkylamides and their use as fungicides |
| 01/04/2006 | CN1234702C Benzopyran compound, and pharmaceutical composition including them |
| 01/04/2006 | CN1234694C New imidazoline compound, its preparation method and drug composition containing them |
| 01/04/2006 | CN1234693C Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 01/03/2006 | US6982334 Crystalline form of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperindine-3-carboxylic acid |
| 01/03/2006 | US6982331 Synthesis of chlorinated pyrimidines |
| 01/03/2006 | US6982272 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis |
| 01/03/2006 | US6982267 For therapy of metabolic and eating disorders such as obesity and hyperphagia, and therapy of diabetes |
| 01/03/2006 | US6982264 Enzyme inhibitors of beta-secretase-mediated cleavage of amyloid precuror proteins; congnition activators; Down's syndrome; Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-type; Parkinson's disease; hemostatic agents |
| 01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 01/03/2006 | CA2343236C 4,4-biarylpiperidine derivatives |
| 01/03/2006 | CA2247451C Carboxylic acid derivatives having fused rings as retinoic acid receptor agonist |
| 01/03/2006 | CA2244695C Cyclic amic acid derivatives |
| 01/03/2006 | CA2187449C Anti-cancer compounds containing cyclopentaquinazoline ring |
| 12/29/2005 | WO2005123727A1 3-aryl-3-hydroxy- and 3-aryl-3-oxopropionic acid esters as fungicides |
| 12/29/2005 | WO2005123724A1 2,4-diaminoquinazolines for spinal muscular atrophy |
| 12/29/2005 | WO2005123722A1 Heterocyclic carboxamides with microbiocidal activity |
| 12/29/2005 | WO2005123715A1 Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors |
| 12/29/2005 | WO2005123697A1 Quinazoline derivatives |
| 12/29/2005 | WO2005123696A1 Substituted quinazolones as anti-cancer agents |
| 12/29/2005 | WO2005123695A1 Process for producing iminoquinazolinone derivative |
| 12/29/2005 | WO2005123693A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 12/29/2005 | WO2005123692A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 12/29/2005 | WO2005123687A1 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments |
| 12/29/2005 | WO2005123680A1 Six-membered heterocycles useful as serine protease inhibitors |
| 12/29/2005 | WO2005123671A1 Pyrrole derivative |
| 12/29/2005 | WO2005123089A2 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 12/29/2005 | WO2005123050A2 Five-membered heterocycles useful as serine protease inhibitors |
| 12/29/2005 | WO2005086656A3 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes |
| 12/29/2005 | WO2005051974A3 Novel molecules for regulating cell death |
| 12/29/2005 | WO2004106295A3 Substituted piperodines and pyrrolidines as calcium sensing receptor modulators and method |
| 12/29/2005 | US20050288445 Reverse synthetic methods for making organic non-linear optical materials |
| 12/29/2005 | US20050288376 Bicyclyl or heterobicyclylmethanesulfonylanimo-substituted N-hydroxyformamides |
| 12/29/2005 | US20050288358 In which the amino is substituted by arylmethyl- or heteroarylmethyl- group, e.g., 2-Methoxybenzyl)-(2-phenylpyrrolidin-3-yl)-amine and 5-{[2-(3-Chloro-phenyl)-pyrrolidin-3-ylamino]-methyl}-6-methoxy-3-methyl-1,1a,3,7b-tetrahydro-3-aza-cyclopropa[a]naphalen-2-one; neurokinin 1 (Substance P) inhititors |
| 12/29/2005 | US20050288357 e.g. 4-(2-{2-[4-hydroxy-4-(1-propylcyclobutyl)but-1-enyl]-5-oxopyrrolidin-1-yl}ethyl)benzoic acid; antiinflammatory, hypotensive, antiulcer agent |
| 12/29/2005 | US20050288354 peroxisome proliferator activated receptor scaffold and modulator; 3-[1-(4-butoxy-benzenesulfonyl)-5-metoxy-1H-indol-3-yl]-propionic acid methyl etster; for identification or development of additional active compound; bioassay: binding affinity or specificity; antidiabetic, obesity, metabolic disorder |
| 12/29/2005 | US20050288353 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| 12/29/2005 | US20050288350 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin |
| 12/29/2005 | US20050288347 Certain triazole-based compounds, compositions, and uses thereof |
| 12/29/2005 | US20050288335 Triamide-substituted heterobicyclic compounds |
| 12/29/2005 | US20050288314 2,4-diaminoquinazolines for spinal muscular atrophy |
| 12/29/2005 | US20050288308 11B-HSD1 inhibitors for the treatment of diabetes |